Marquette Asset Management’s Pliant Therapeutics PLRX Stock Holding History

Marquette Asset Management’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-174,500	Closed	-$199K	–	886
2026 Q2	$199K	Buy	+174,500	New	+$212K	0.03%	103

Other funds holding PLRX

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Marquette Asset Management's PLRX Position: Q3 2026 in Review

Marquette Asset Management sold out of Pliant Therapeutics (PLRX) in Q3 2026, closing a stake of 174,500 shares — an estimated $199K sold.

Marquette Asset Management first reported a position in PLRX in Q2 2026 and held it in 1 quarter. The position peaked at $199K in Q2 2026. 1 fund tracked by Wall St. Rank holds PLRX as of Q3 2026.

Marquette Asset Management reported no remaining Pliant Therapeutics position as of Q3 2026 after selling out during the quarter.
Marquette Asset Management sold 174,500 Pliant Therapeutics shares in Q3 2026, an estimated $199K.
Marquette Asset Management first reported a position in Pliant Therapeutics in Q2 2026 and held it in 1 quarter.
Marquette Asset Management's Pliant Therapeutics position peaked at $199K in Q2 2026.
1 fund tracked by Wall St. Rank held Pliant Therapeutics as of Q3 2026.

Based on Marquette Asset Management's 13F filing for Q3 2026, filed 9 Oct 2026.